Clinical Trial Update: Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating interferon alfa and interleukin-6 in patients with recurrent multiple myeloma; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Interleukin-6 (Interleukin-6)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2018-11-16